864815-50-9

Upstream product

• 148164-03-8 1,5-anhydro-3-O-benzoyl-4-O-benzyl-2,6-dideoxy-L-arabino-hex-1-enitol 
• 81927-56-2 methyl 4,6-O-benzylidene-2-deoxy-2-phthalimide-β-D-glucopyranoside 
• 864815-46-3 ethyl 3-O-benzoyl-4-O-benzyl-2-chloro-2-deoxy-1-thio-α-L-rhamnopyranoside 

Downstream Products

• 864815-52-1 methyl (2,3,4-tri-O-benzyl-α-L-mannopyranosyl)-(1->3)-(4-O-benzyl-2-chloro-2-deoxy-α-L-rhamnopyranosyl)-(1->3)-4,6-O-benzylidene-2-deoxy-2-(N-fluorenylmethoxycarbonyl-β-alanyl)-amido-β-D-glucopyranoside 
• 864815-53-2 methyl (2,3,4-tri-O-benzyl-α-L-mannopyranosyluronyl)-(1->3)-(4-O-benzyl-2-chloro-2-deoxy-α-L-rhamnopyranosyl)-(1->3)-2-(3-aminopropionamido)-4,6-O-benzylidene-2-deoxy-β-D-glucopyranoside lactam 

Relevant academic research and scientific papers

Developing high affinity oligosaccharide inhibitors: Conformational pre-organization paired with functional group modification

Intramolecular tethering combined with functional group modification has been investigated as an approach to design high affinity oligosaccharide ligands. The preceding paper reported successful tethering to constrain a trisaccharide in the conformation o